Viridian Therapeutics Inc - VRDN - stock price prediction, stock price target, analyst ratings from 17 analysts

Viridian Therapeutics Inc has a share price target of US$ 38, revenue growth forecast of 5356.7%, and profit growth estimate of -34.9% for FY25, based on top 17 analyst calls.